Jennifer Price, MD

Email Jennifer
(415) 502-1429

513 Parnassus Ave, MSB
San Francisco, CA 94117

Visit CTSI Profile

  • Associate Professor, School of Medicine

Biography

Dr. Jennifer Cohen Price is an Assistant Clinical Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include liver disease in HIV infection, the natural history and treatment of viral hepatitis, and nonalcoholic fatty liver disease.

Awards

Displaying 1 - 62 of 62

  1. Dias JP, Haberlen SA, Dobs AS, Lake JE, Palella FJ, Kingsley LA, Price JC, Basaria S, Varadhan R, Margolick JB, Thio CL, Brown TT. Longitudinal changes in sex hormone-binding globulin in men with HIV. J Acquir Immune Defic Syndr. 2021 May 10. View on Pubmed
  2. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Non-viral Liver Disease is the Leading Indication for Liver Transplant in the U.S. in Persons Living with Human Immunodeficiency Virus. Am J Transplant. 2021 Mar 22. View on Pubmed
  3. McIntosh AT, Wei R, Ahn J, Aouizerat BE, Kassaye SG, Augenbraun MH, Price JC, French AL, Gange SJ, Anastos KM, Goldman R. A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women. PLoS One. 2021; 16(3):e0247277. View on Pubmed
  4. Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ, AASLD COVID-19 Vaccine Working Group . AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease. Hepatology. 2021 Feb 12. View on Pubmed
  5. Kardashian A, Wilder J, Terrault NA, Price JC. Addressing Social Determinants of Liver Disease during the COVID-19 Pandemic and Beyond: A Call to Action. Hepatology. 2020 Nov 04. View on Pubmed
  6. Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, Price JC, Chew KW, Chung RT, Corey KE. Expert Panel Review on Non-Alcoholic Fatty Liver Disease in Persons With HIV. Clin Gastroenterol Hepatol. 2020 Oct 16. View on Pubmed
  7. Maurice JB, Goldin R, Hall A, Price JC, Sebastiani G, Morse CG, Prat L, Perazzo H, Garvey L, Ingiliz P, Guaraldi G, Tsochatzis E, Lemoine M. Increased BMI and Type 2 diabetes are the main predictors of NAFLD and advanced fibrosis in liver biopsies of patients with HIV mono-infection. Clin Infect Dis. 2020 Sep 02. View on Pubmed
  8. Jenny Pena Dias, Sabina Haberlen, Adrian Dobs, Jordan Lake, FranK J Palella, Lawrence Kingsley, Shehzad Sultan Basaria, Jennifer C Price, Matt Budoff, Chloe L Thio, Todd Tarquin Brown. SAT-LB134 Aging Related Changes in Sex Hormone-Binding Globulin in Men With HIV. Journal of the Endocrine Society. 2020 May 8; 4(Suppl 1). View on Pubmed
  9. Guaraldi G, Maurice JB, Marzolini C, Monteith K, Milic J, Tsochatzis E, Bhagani S, Morse CG, Price JC, Ingiliz P, Lemoine M, Sebastiani G. New Drugs for NASH and HIV Infection: Great Expectations for a Great Need. Hepatology. 2020 May; 71(5):1831-1844. View on Pubmed
  10. Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. View on Pubmed
  11. Tien PC, Duarte M, Roque A, Price J. MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One? Dig Dis Sci. 2020 04; 65(4):928-930. View on Pubmed
  12. Kardashian A, Peters MG, Tien PC, Price JC. The Pathogenesis of Liver Disease in People Living With Human Immunodeficiency Virus: The Emerging Role of the Microbiome. Clin Liver Dis (Hoboken). 2020 Jan; 15(1):46-51. View on Pubmed
  13. Price JC, Bhattacharya D. Editorial: HBV-the promise of a new era in therapeutics. Aliment Pharmacol Ther. 2020 02; 51(4):479-480. View on Pubmed
  14. Golovaty I, Tien PC, Price JC, Sheira L, Seligman H, Weiser SD. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States. J Nutr. 2020 01 01; 150(1):91-98. View on Pubmed
  15. S. Moron-Lopez, G. Xie, P. Kim, J. Wong, J. Price, N. Elnachef, R. Greenblatt, P. Tien, N. Roan, S. Yukl. OP 7.6 Tissue-specific differences in the mechanisms that govern HIV latency in blood, liver, gut and genital tract in ART-suppressed women. Journal of virus eradication. 2019 Dec 1; 5:40. View on Pubmed
  16. Durand CM, Werbel W, Doby B, Brown D, Desai NM, Malinis M, Price J, Chin-Hong P, Mehta S, Friedman-Moraco R, Turgeon NA, Gilbert A, Morris MI, Stosor V, Elias N, Aslam S, Santos CAQ, Hand JM, Husson J, Pruett TL, Agarwal A, Adebiyi O, Pereira M, Small CB, Apewokin S, Heun Lee D, Haidar G, Blumberg E, Mehta SA, Huprikar S, Florman SS, Redd AD, Tobian AAR, Segev DL. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. Am J Transplant. 2020 02; 20(2):617-619. View on Pubmed
  17. Kaplan, A. Price, J.C.. HIV-Associated NAFLD: Disease Burden and Management. Curr Hepatology Rep. 2019; (18):482-491. View on Pubmed
  18. Price JC, Wang R, Seaberg EC, Brown TT, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Lake JE, Thio CL. Sex Hormone-Binding Globulin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease in HIV-Infected and -Uninfected Men. Open Forum Infect Dis. 2019 Dec; 6(12):ofz468. View on Pubmed
  19. Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women. AIDS. 2019 11 01; 33(13):2025-2033. View on Pubmed
  20. Kardashian A, Ma Y, Yin MT, Scherzer R, Nolan O, Aweeka F, Tien PC, Price JC. High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected Women. Open Forum Infect Dis. 2019 Jul; 6(7):ofz281. View on Pubmed
  21. Kardashian A, McKinney J, Huynh N, Yu R, Peters M, Catalli L, Price JC. Post-sustained Virologic Response Liver Stiffness May Underestimate Fibrosis After Direct Acting Antiviral-containing Therapy. Clin Infect Dis. 2019 05 02; 68(10):1784-1787. View on Pubmed
  22. Ani Kardashian, Yifei Ma, Michael T. Yin, Rebecca Scherzer, Olivia Nolan, Francesca Aweeka, Phyllis Tien, Jennifer Price. Su1080 – High Kynurenine:Tryptophan Ratio is Associated with Liver Fibrosis in Hiv Infection. Gastroenterology. 2019 May 1; 156(6):s-1269. View on Pubmed
  23. Price JC, McKinney JE, Crouch PC, Dillon SM, Radix A, Stivala A, Carollo JR, Fierer DS. Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIV. J Infect Dis. 2019 04 16; 219(9):1373-1376. View on Pubmed
  24. Price JC, Seaberg EC, Stosor V, Witt MD, Lellock CD, Thio CL. Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men. AIDS. 2018 11 13; 32(17):2636-2638. View on Pubmed
  25. Mellor-Crummey LE, Lake JE, Wilhalme H, Tseng CH, Grant PM, Erlandson KM, Price JC, Palella FJ, Kingsley LA, Budoff M, Post WS, Brown TT. A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus. J Clin Gastroenterol Hepatol. 2018; 2(3). View on Pubmed
  26. J. Price, R. Wang, E. Seaberg, T. Brown, M. Budoff, L. Kingsley, F.P. Jr, M. Witt, W. Post, J. Lake, C. Thio. SAT-523 Sex hormone binding globulin levels are increased in HIV-infected men and are independently associated with lower odds of nonalcoholic fatty liver disease regardless of HIV serostatus. Journal of Hepatology. 2018 Apr 1; 68:s840. View on Pubmed
  27. Reid M, Ma Y, Scherzer R, Price JC, French AL, Huhn GD, Plankey MW, Peters M, Grunfeld C, Tien PC. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus. J Infect Dis. 2018 03 28; 217(8):1289-1297. View on Pubmed
  28. Mellor-Crummey LE, Lake JE, Wilhalme H, Tseng CH, Grant PM, Erlandson KM, Price JC, Palella Jr FJ, Kingsley LA, Budoff M, Post WS, Brown TT. A Comparison of the Liver Fat Score and CT Liver-to-Spleen Ratio as Predictors of Fatty Liver Disease by HIV Serostatus. J Clin Gastroenterol Hepatol. 2018; 2:No.3:16 doi: 10.21767/2575-773. View on Pubmed
  29. Reid M, Price JC, Tien PC. Hepatitis C Virus Infection in the Older Patient. Infect Dis Clin North Am. 2017 12; 31(4):827-838. View on Pubmed
  30. Price JC, Tien PC. Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression? Am J Gastroenterol. 2017 Oct; 112(10):1506-1507. View on Pubmed
  31. Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski S, Tien PC. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults. AIDS. 2017 09 24; 31(15):2119-2125. View on Pubmed
  32. Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infect Dis. 2017; 4(3):ofx153. View on Pubmed
  33. Price JC, Tien PC. Reply. Hepatology. 2017 08; 66(2):674-675. View on Pubmed
  34. Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology. 2017 03; 65(3):853-863. View on Pubmed
  35. Reid M, Ma Y, Scherzer R, Price JC, French AL, Plankey MW, Grunfeld C, Tien PC. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS. 2017 01 28; 31(3):385-393. View on Pubmed
  36. Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Sex differences in the association of HIV infection with hepatic steatosis. AIDS. 2017 01 28; 31(3):365-373. View on Pubmed
  37. Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA. Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol. 2017; 30(1):83-88. View on Pubmed
  38. Jennifer Price, Jennifer Dodge, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion Peters, Sue Noworolski, Phyllis Tien. Correlation of Controlled Attenuation Parameter and Magnetic Resonance Spectroscopy Measurements of Hepatic Steatosis in HIV-positive Adults. The American Journal of Gastroenterology. 2016 Oct 1; 111:s371. View on Pubmed
  39. Konerman MA, Price JC, Campbell CY, Eluri S, Gurakar A, Hamilton J, Li Z. Pre-Liver Transplant Transthoracic Echocardiogram Findings and 6-Month Post-Transplant Outcomes: A Case-Control Analysis. Ann Transplant. 2016 Jul 05; 21:416-27. View on Pubmed
  40. Price JC, Seaberg EC, Phair JP, Witt MD, Koletar SL, Thio CL. Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. . 2016 07 01; 72(3):319-23. View on Pubmed
  41. Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant. 2015 Jun; 20(3):276-85. View on Pubmed
  42. Price JC, Terrault NA. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34. View on Pubmed
  43. Price JC, Terrault NA. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8. View on Pubmed
  44. Konerman MA, Price J, Torres D, Li Z. Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods. Therap Adv Gastroenterol. 2014 Sep; 7(5):184-92. View on Pubmed
  45. Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci. 2014 Dec; 59(12):3043-52. View on Pubmed
  46. Chen T, Hubbard A, Murtazina R, Price J, Yang J, Cha B, Sarker R, Donowitz M. Myosin VI mediates the movement of NHE3 down the microvillus in intestinal epithelial cells. J Cell Sci. 2014 Aug 15; 127(Pt 16):3535-45. View on Pubmed
  47. Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol. 2014 May; 109(5):695-704. View on Pubmed
  48. Jodorkovsky D, Price JC, Kim B, Dhalla S, Stein EM, Clarke JO. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2014 Aug; 59(8):1817-22. View on Pubmed
  49. Price J. An update on hepatitis B, D, and E viruses. Top Antivir Med. 2014 Jan; 21(5):157-63. View on Pubmed
  50. Jennifer C. Price. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatology Reports. 2013 Dec 1; 12(4):227-235. View on Pubmed
  51. Jennifer Price, Valentina Shvachko, Rosemary Murphy, Michele M. Manos. Characteristics of HCV Direct Acting Antiviral Treatment Initiators in a Large Integrated Care Setting. The American Journal of Gastroenterology. 2013 Oct 1; 108:s151.
  52. Jennifer Price, Eric Seaberg, Anand Mehta, Sheila Badri, Mallory Witt, Kristin D'Acunto, Chloe Thio. Non-invasive Liver Fibrosis Markers Are Associated with Liver-Related Death in the Multicenter AIDS Cohort Study. The American Journal of Gastroenterology. 2013 Oct 1; 108:s153.
  53. Gulsen MT, Girotra M, Cengiz-Seval G, Price J, Singh VK, Segev DL, Cameron AM, Gurakar A. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant. 2013 Feb 20; 18:69-75.
  54. Price JC. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatitis Reports. 2013; 12(4):227-235.
  55. Price J, Thio C. Reply to Post and Sabin. J Infect Dis. 2013 Jan 15; 207(2):368-9.
  56. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012 Mar 15; 205(6):1005-13.
  57. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1002-12.
  58. Liang DB, Price JC, Ahmed H, Farmer N, Montgomery EA, Giday SA. Gastric sarcoidosis: case report and literature review. J Natl Med Assoc. 2010 Apr; 102(4):348-51.
  59. Price J and Li Z. . Hepatitis B- Recent Developments in Therapy. European Gastroenterology & Hepatology Review. 2009; 5(1):38-42.
  60. O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes. J Gen Intern Med. 2006 Jun; 21(6):570-6.
  61. Miller RG, Ashar BH, Cohen J, Camp M, Coombs C, Johnson E, Schneyer CR. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005 Sep; 20(9):847-51.
  62. Cohen JG, Dryja TP, Davis KB, Diller LR, Li FP. RB1 genetic testing as a clinical service: a follow-up study. Med Pediatr Oncol. 2001 Oct; 37(4):372-8.